Drug
S 707106 Dose A
S 707106 Dose A: highest development phase Phase 2, developed by Shionogi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| S-707106 Dose A NCT01240759 | Phase 2 | Type 2 Diabetes Mellitus |
Latest
No recent events.
Follow S 707106 Dose A on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.